Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Longenesis is a medical technology company specializing in creating secure and ethical platforms for biomedical organizations. Their tools enable compliant data sourcing, patient consent management, and research collaboration, aiming to accelerate biomedical advancements and personalized medicine while prioritizing data privacy and patient engagement. They focus on providing a technological bridge for biomedical institutions, patient organizations, and research partners.
Serves as the primary hub for strategic direction, global operations management, core technology development, and international business partnerships.
Modern office facilities within a prime commercial building, the FWD Financial Centre, designed to foster collaboration and innovation. Specific architectural details are not publicly emphasized.
A dynamic and mission-driven work culture focused on ethical innovation in health-tech. Emphasizes collaboration, agility, and a commitment to data privacy and patient-centric solutions. Employees typically experience a fast-paced startup environment.
Hong Kong's position as a global financial center and gateway to Asia provides strategic advantages for international partnerships, talent acquisition, and access to emerging biotech markets.
Longenesis globally supports ethical biomedical data sourcing, secure data curation, patient consent management, clinical trial engagement, and research collaboration through its SaaS platform. This includes facilitating international research projects, ensuring data privacy compliance across jurisdictions (like GDPR), and enabling remote patient interaction for studies, with key operational focuses in Asia and Europe.
Suite 1701-02, 17/F, FWD Financial Centre, 308 Des Voeux Road Central
Sheung Wan, Hong Kong
Hong Kong SAR
Hong Kong
Address: Specific street address not publicly listed; operates within Luxembourg's business district.
To establish a strong presence in the European Union, ensuring adherence to regional data protection regulations and fostering collaborations within the European life sciences ecosystem.
Address: Specific street address not publicly listed; likely co-located or closely working with local partners like HLB Group.
To drive adoption of Longenesis' platform in the technologically advanced South Korean market, supporting local biomedical research and healthcare innovation.
Address: Specific street address not publicly listed; potential R&D or European operational support office.
To support European operations with skilled technical talent and foster innovation, benefiting from Latvia's growing tech scene and strategic location in Northern Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Longenesis' leadership includes:
Longenesis has been backed by several prominent investors over the years, including:
No major publicly announced C-suite executive hires or departures have been noted for Longenesis in the last 12 months. The core leadership team, including the COO appointed in late 2022, appears stable.
Discover the tools Longenesis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Longenesis likely utilizes common corporate email formats. While not publicly specified, patterns such as [first_initial][last]@[companyname].com or [first].[last]@[companyname].com are frequently adopted by tech companies. The format [first_initial][last]@longenesis.com is a probable structure.
[first_initial][last]@longenesis.com
Format
sjakimov@longenesis.com
Example
80%
Success rate
Cision PR Newswire • October 5, 2023
Longenesis announced the launch of its advanced consent management platform with the University of Warmia and Mazury in Olsztyn, Poland, aiming to enhance ethical data collection and research capabilities for academic and clinical studies....more
Business Wire • April 19, 2023
Longenesis and Medidata, a Dassault Systèmes company, have partnered to integrate Longenesis' patient-centric data engagement and consent solutions with Medidata's comprehensive clinical trial platform to improve overall data management efficiency and patient experience in clinical research....more
EIN Presswire • February 28, 2023
Longenesis announced a collaboration with Merck Sharp & Dohme (MSD) to explore opportunities for enhancing patient-centric research and engagement in the Asia Pacific region, leveraging Longenesis' digital patient consent and communication tools....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Longenesis, are just a search away.